Approval of financial results for the quarter and financial year ended on March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Archit Organosys Limited reported strong FY2025-26 results with revenue from operations growing 12.2% to Rs. 14,095.25 Lacs from Rs. 12,559.92 Lacs in the previous year. Profit After Tax surged 59% to Rs. 803.21 Lacs (vs Rs. 505.11 Lacs), significantly outpacing revenue growth and indicating improved operational efficiency. Earnings per share improved from Rs. 2.46 to Rs. 3.91. The Board recommended a final dividend of Rs. 1 per share (10% on Rs. 10 face value). Statutory auditors M/s G.K. Choksi & Co. issued an unmodified (clean) audit opinion, confirming true and fair view of financial statements. Cash and cash equivalents improved substantially to Rs. 137.41 Lacs from Rs. 6.81 Lacs, while borrowings were reduced.
The company delivered robust profit growth driven by improved margins, indicating operational efficiency gains. The clean audit opinion and dividend declaration signal financial stability and shareholder-friendly policies. However, revenue growth of 12% is below the 20% threshold, suggesting moderate rather than exceptional expansion.